Latest Financials News

Elixir Energy has raised approximately AUD 16.6 million through a two-tranche placement led by Omega Oil & Gas, aiming to fast-track its Taroom Trough gas projects and advance toward commercial production.

Fisher & Paykel Healthcare reported a robust 14% revenue increase and a 39% jump in net profit for the first half of fiscal 2026, driven by strong clinical adoption and product innovation.

Brazilian Critical Minerals Ltd has been served with a writ alleging breach of a convertible loan agreement tied to share issuance and pricing, sparking a legal dispute with a US investment firm.

Aura Energy’s 2025 AGM highlights strong uranium market fundamentals and strategic progress on its Tiris Project, despite some engineering delays. The company also strengthens its board and deepens ties in Mauritania as it prepares for production.

Dalrymple Bay Infrastructure has declared its Q3-25 distribution consistent with its full-year guidance, reinforcing its commitment to stable returns backed by its key coal export terminal.

West African Resources is advancing negotiations with the Burkina Faso Government over equity interests in its Kiaka gold project, proposing alternatives to direct government ownership to boost national benefits without diluting shareholder value.

Osteopore Limited has drawn an additional A$250,000 under the first tranche of its redeemable convertible notes, continuing its steady capital raise to support growth and innovation.

Nex Metals Explorations reported no exploration spending in Q1 FY26 but made significant strides by finalising a profit-sharing deal for its Kookynie project and entering Egypt’s Eastern Desert mining scene.

Entertainment Rewards Ltd has issued a Target’s Statement recommending shareholders accept Suzerain Investment Holdings’ conditional off-market takeover offer at a significant premium. An independent expert concurs the offer is fair and reasonable, setting the stage for potential full ownership by Suzerain.

Global Masters Fund Limited (GFL) reported a robust 19.8% total return for FY2025, surpassing the MSCI World Index, while unveiling strategic moves to diversify beyond Berkshire Hathaway into private growth and regional quality funds.

Zelira Therapeutics has received a $1.07 million cash refund under Australia’s R&D Tax Incentive Scheme, reinforcing its funding for ongoing clinical trials and product development. The company has also repaid a prior loan advanced against this claim, positioning it for continued growth in cannabinoid-based medicines.

Vault Minerals has settled all its gold forward sales contracts for the second half of FY26 six months early, boosting its exposure to rising gold prices and reinforcing its shareholder value strategy.